Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohn Laing Infrastructure Fund Regulatory News (JLIF)

  • There is currently no data for JLIF

Form 8.5 (EPT/NON-RI) - Replacement

19 Jul 2018 15:17

RNS Number : 2086V
Macquarie Capital (Europe) Limited
19 July 2018
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

Please note that this is an amendment to form 9246U section 2(a)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Macquarie Capital Europe Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

John Laing Infrastructure Fund Limited

(c) Name of the party to the offer with which exempt principal trader is connected:

John Laing Infrastructure Fund Limited

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16/07/2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

0

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

ORD SHARES

Purchase

50382

137.6

126.2

ORD SHARES

Sale

50382

139.8

121

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19/07/2018

Contact name:

Petra de Beer

Telephone number:

02030372623

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOXKLFFVDFEBBD
Date   Source Headline
17th May 20182:28 pmRNSResults of AGM and EGM
11th Apr 20187:00 amRNSNotice of AGM and EGM
4th Apr 20184:28 pmRNSDirector/PDMR Shareholding
23rd Mar 20187:01 amRNS2017 Second Interim Dividend
23rd Mar 20187:00 amRNSResults for the year ended 31 December 2017
14th Mar 20186:23 pmRNSHolding(s) in Company
8th Mar 20187:00 amRNSNotice of Results
23rd Feb 20184:51 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSFurther update regarding liquidation of Carillion
16th Jan 20187:00 amRNSUpdate regarding liquidation of Carillion plc
15th Jan 20181:12 pmRNSKey Information Document Update
11th Jan 20184:00 pmRNSChange of Name of Administrator/ Company Secretary
21st Dec 201712:57 pmRNSKey Information Document
23rd Nov 20172:52 pmRNSHolding(s) in Company
21st Nov 20179:14 amRNSHolding(s) in Company
13th Nov 20176:25 pmRNSAudit Committee Changes
13th Nov 20177:00 amRNSTrading Update Statement
1st Nov 20177:00 amRNSTotal Voting Rights
30th Oct 20177:00 amRNSIssue of Equity
23rd Oct 20177:00 amRNSAgreement of Acquisition
29th Sep 20177:00 amRNSScrip Dividend Circular
11th Sep 20177:00 amRNS2017 First Interim Dividend
11th Sep 20177:00 amRNSInterim results
2nd Aug 20173:13 pmRNSHolding(s) in Company
1st Aug 201710:00 amRNSNotice of Results
17th Jul 201710:30 amRNSHolding(s) in Company
12th Jul 20172:16 pmRNSDirector Declaration
6th Jul 20177:00 amRNSDirectorate Change
1st Jun 20174:13 pmRNSCompletion of Acquisition
1st Jun 20177:00 amRNSTotal Voting Rights
19th May 20172:21 pmRNSResult of AGM
19th May 20177:00 amRNSTrading Update Statement
15th May 20177:00 amRNSScrip Allocation
11th Apr 20177:01 amRNSScrip Dividend Circular
11th Apr 20177:00 amRNSNotice of AGM
3rd Apr 20177:00 amRNSTotal Voting Rights
31st Mar 20174:40 pmRNSHolding(s) in Company
27th Mar 20173:25 pmRNSPlacing of 89,826,897 new ordinary shares
20th Mar 20177:03 amRNSPlacing of up to 89.8m of New Ordinary Shares
20th Mar 20177:02 amRNS2016 Second Interim Dividend
20th Mar 20177:00 amRNSPreliminary results for the year ended 31 Dec 2016
14th Feb 20177:00 amRNSNotice of Results
30th Dec 20167:00 amRNSCompletion of Acquisition
23rd Dec 20167:00 amRNSCompletion of Acquisition
21st Dec 20167:00 amRNSAgreement of Acquisition
13th Dec 201611:01 amRNSHolding(s) in Company
9th Dec 20167:00 amRNSAgreement of Acquisition
7th Nov 20167:00 amRNSTrading Update Statement
1st Nov 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSShare Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.